OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Charity number: 1140271 Company number: 7378488

Bowel Cancer West

(A company limited by guarantee)

Trustees' report and financial statements

for the period ended 31 December 2025

Bowel Cancer West (A company limited by guarantee)

Contents

Page
Legal and administrative information 1
Trustees' report 2 - 5
Independent examiners' report 6
Statement of financial activities 7
Balance sheet 8 - 9
Notes to the financial statements 10 - 17

Bowel Cancer West

(A company limited by guarantee)

Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025

Charity number 1140271 Company registration number 7378488 Business address and Registered office Best Accountancy Services (Plymouth) Limited Unit 7, Seaton Business Park 36 William Prance Road Plymouth PL6 5WR Directors/Committee Mr M Coleman Chairman Mr J Best Treasurer Mr J Mills (resigned 31[st] October 2025) Ms D Sheppard (Vice Chair) Mrs S Coleman Ms S Davarian Mr H Mckenzie Mr G Pattison Mr P Menis Mrs N Fishwick (appointed 15[th] July 2026) Accountants Best Accountancy Services (Plymouth) Ltd Unit 7, Seaton Business Park 36 William Prance Road Plymouth PL6 5WR Bankers National Westminster Bank plc

Page 1

Bowel Cancer West (A company limited by guarantee)

Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025

The trustees present their report and the financial statements for the year ended 31 December 2025. The trustees, who are also directors of Bowel Cancer West for the purposes of company law and who served during the year and up to the date of this report are set out on page 1.

Structure, governance and management

Structure, governance and management Bowel Cancer West is a registered charity, number 1140271 and is constituted under The Companies Act 2006 as a Private Company Limited by Guarantee and governed by the Articles of Association of Bowel Cancer West. Company number 7378488.

The charity was established in 2010 for research and education in the specialty of bowel cancer, and for developing the public awareness of the disease in the west of England. The charity's strap-line Awareness, Research, Training tries to capture this. The charity's main aim is to improve survival rates of people with bowel cancer in the southwest of the UK. New directors are appointed by the existing directors. Retirement of directors is by rotation at the Annual General Meeting in accordance with the Memorandum and Articles of Association. The Articles of Association provides for a minimum of 3 directors but shall not be subject to any maximum.

The overall responsibility for the work of the charity lies with the Board of Trustees who help shape the strategy and approve plans to deliver the Charity's aims. Progress is monitored and evaluated at board meetings (every 2-3 months) where the board receive regular reports from the Executive Director or Vice Chair.

A new part-time Chief Executive (Caroline Bramwell) was appointed in February 2025, however she resigned with the support of the Board, as the financial objectives were not met. The role reverted to Diane Sheppard, Vice-Chair as an unpaid part-time role. From August 2025 there are no paid employees within the charity, meaning that all funds raised entirely support the charities aims.

A financial statement and strategic update is prepared and presented to the Board along with papers to enable Board members to comment if they are unable to attend the meeting. Careful stewardship of the charity's resources is a key element of the meeting. All directors give their time freely. An expe nse claim policy is in place and any payments made are shown through the accounts. Directors are required to disclose all relevant interests and register them with the Chair and in accordance with the Articles of Association withdraw from decisions where a conflict of interest arises. The directors long term aim is to ensure that membership is well balanced from a clinical and business perspective as well as that of people who have experienced bowel cancer. Clinical representation is reflected in the appointment of the Chairman who is a consultant surgeon and Vice Chair who is a senior nurse. Trustee appointments that enable local networking and establish the charity within the business community are also vital for the charity’s success.

Risk management

Key risks include the support of research projects. A Sub-committee is consulted around the appropriateness of the funding. Integral to this is the need for ethical approval from the associated hospital trust or university research and development department. Any such studies will require a 'sponsor' which will usually be the hospital trust or university. The sponsor then provides the indemnity for the research project and although Bowel Cancer West provides the funding for the research project it is free of any contingent liability. Funding will not be released until proof of ethical approval and sponsorship is provided by the candidate. The candidate is required to document and record such approvals and to provide progress updates to Bowel Cancer West and the Sponsor.

Bowel Cancer West has public liability insurance. Risk assessments are undertaken as necessary, for example the use of the smoothie bike.

The charity shop had health and safety and fire risk assessments undertaken on a regular basis by the shop manager who reported the outcome and need for action to the Vice Chair. Appropriate vetting of volunteers working in the shop.

Page 2

Bowel Cancer West

(A company limited by guarantee)

Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025

Objectives and activities

The Directors confirm that they have referred to the guidance contained in the Charity Commission's general guidance on the public benefit when reviewing the charity's aims and objectives and in planning future activities and setting the grant making policy for the year.

A new strategy was agreed with the Board on an away day in October 2024 with input from an expert in bowel cancer and screening to challenge the directors in their thinking. The aim is to try and ensure that awareness raising is prioritised in areas where there is a lower return rate of national bowel screening and higher incidence of bowel cancer

Achievements and performance

The Board took the decision at the beginning of 2025 to close the charity shop when the three-year shop lease was due for renewal in May 2025. Due to increasing running costs such as utilities, rates and minimum wages, the cost of running the shop was higher than the income received, even though the shop was very well supported in the local community.

The remaining stocks and assets were decanted to a smaller unit and sold through various fares and online. The unit was rented for 6 months with notice given in October 2025.

For the fourth year running the charity has assisted with the running of the Devon and Cornwall Backyard Ultra, which is an endurance running event which was held in Newnham Park, Plymouth in August. The event was supported by our Treasurer John Best who successfully attracted runners and sponsors for the event, which generated a substantial profit for the charity as well as promoting the importance of fitness is supporting the prevention of bowel cancer. A separate website is established for this event focusing on the running community.

The charities website was totally revamped over 2025, with a company’s time purchased assist with the ongoing maintenance of the website.

Research

Bowel Cancer West has partnered with the University of Cardiff to fund research into LARS. LARS (Lower Anterior Resection Syndrome) can be a complication for patients who have had part of their rectum removed from cancer. The project has resulted in the production of educational resources for patients and clinicians and the management techniques that are available and most suitable for their symptoms.

Training

No funding has been allocated for training due to the current financial pressures associated with the hospital shop and appointment of a chief executive. Plans are in place to start funding training during 2026.

Awareness

Awareness events included Liskeard Show, Yealmpton Show and Devon County Show all of which have a large football of many thousands of people. There are many people attending from the farming community. Farmers are believed to be quite stoical when it comes to their health and therefore raising awareness and the importance of early intervention if you experience symptoms is key to a successful and swift outcome enabling them to return to work.

Awareness raising to carers in Devon has been a focus in partnership with the Wellmore. Several meetings were held across the county talking to carers about bowel cancer and recognising symptoms and the benefits of early diagnosis.

The charity continues to be supported by local organisations nominating the charity as their charity of the year and by people who raise funds through sponsored running events.

Page 3

Bowel Cancer West

(A company limited by guarantee)

Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025

BCW Team Members

Our fund raising and events lead resigned in February 2025 and due to issues with finances it was agreed to not replace her but continue with the Chief Executive. As mentioned previously the Chief Executive also resigned in August 2025. With the closure of the shop this has given the opportunity for the finances to recover.

The team is very well supported by a voluntary administrator who supports the team ensuring Board meetings are organised and recorded and that awareness materials are available and administers research requests as well as paying invoices and banking income.

Financial review

In the 2025 financial year funds deployed by the charity (excluding governance costs) were £48,685 in the previous 12 months it was £75,344. The funding was spent on charitable activity expenditure of £48,685. There were no awareness or training costs in the period.

The closure of the shop proved to be a positive decision as no longer a drain on resources.

The ongoing cost of living in the UK has made fundraising a tough thing to achieve in 2025 however the Committee and volunteers worked very hard to attend and run various throughout the year.

The trustees’ have been cautious in the year and have managed the funds available well in trying to make best use of the resources. The trustees also took the difficult decision to terminate the employment of the CEO with the cost of employment being higher than the level of income being realised. The charity required a complete reset, strip and simplify to ensure its survival.

Overall, a loss was realised in 2025 of £7,858.

At the end of 2025 we had unfettered cash reserves of £27,611 compared to £35,469 last year.

Plans for future periods

For 2026 BCW is concentrating on consolidation, with the removal of unnecessary expenses. In tandem, its strategic approach is to:

Through these activities, the charity endeavours to strengthen it’s offering to support those living with bowel cancer, and to encourage early screening to increase the chances of treatment.

Page 4

Bowel Cancer West

(A company limited by guarantee)

Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025

Statement of trustees' responsibilities

The trustees (who are also directors of Bowel Cancer West for the purpose of company law) are responsible for preparing the Trustees' Annual Report and the financial statements in accordance with applicable law and United Kingdom Generally Accepted Accounting Practice.

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and which enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Small company provisions

These financial statements have been prepared in accordance with FRS 102 the Financial Reporting Standard applicable in the UK and Republic of Ireland.

On behalf of the board

.................................

Mr John Best

Honorary Treasurer

Page 5

Bowel Cancer West (A company limited by guarantee)

Independent examiner's report to the trustees on the unaudited financial statements of Bowel Cancer West.

We report on the accounts of Bowel Cancer West for the year ended 31 December 2025 set out on pages 2 to 17.

Respective responsibilities of trustees and independent examiner

As the charity's trustees you are responsible for the preparation of the accounts, you consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 (the 2011 Act) and that an independent examination is needed. It is our responsibility to:

Basis of independent examiner's statement

Our examination was carried out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a 'true and fair view' and the report is limited to those matters set out in the statement below.

Independent examiner's statement

In connection with my examination, no matter has come to my attention:

have not been met; or

...........................................................

Mr Chris Jones FMAAT On behalf of Best Accountancy Services (Newton Abbot) Ltd Licensed and regulated by the Association of Accounting Technicians Independent examiner Licence NO:4513

Page 6

Bowel Cancer West (A company limited by guarantee)

Statement of financial activities (incorporating the income and expenditure account)

For the period ended 31 December 2025

Unrestricted
funds
Notes
£
Incoming resources
Incoming resources from generating funds:
Voluntary income
2
45,112
Investment income
3
30
Grants received
4
-
_
Total incoming resources
45,142
_
Resources expended
Charitable activities
48,685
Governance costs
5
4,315
_
Total resources expended
53,000
_
Net incoming/(outgoing) resources for the year
Net income/(expenditure) for the year
(7,858)
Total funds brought forward
35,469
_
Total funds carried forward
27,611
2025
Total
£
45,112
30
-
_
45,142
_
48,685
4,315
_
53,000
_
(7,858)
35,469
_
27,611
2024
Total
£
81,708
22
-
_
81,730
_
75,344
4,085
_
79,429
_
2,301
33,169
_
35,469

The notes on pages 13 to 19 form an integral part of these financial statements.

Page 7

Bowel Cancer West (A company limited by guarantee)

Balance sheet

as at 31 December 2025

Notes
Fixed assets
Tangible assets
11
Current assets
Debtors
12
Cash at bank and in hand
Creditors: amounts falling
due within one year
13
Net current assets
Net assets
Funds
15
Unrestricted general funds
Total funds
2025
£
£
2,764
417
25,773
_
26,190
(1,343)
_
24,847
_
27,611
_
27,611
_
27,611
2024
£
£
5,205
3,300
29,238
_
32,538
(2,274)
_
30,264
_
35,469
_
35,469
_
35,469

The Balance Sheet continues on the following page.

The notes on pages 13 to 19 form an integral part of these financial statements.

Page 8

Bowel Cancer West

(A company limited by guarantee)

Balance sheet (continued)

Directors statements required by the Companies Act 2006

for the year ended 31 December 2025

In approving these financial statements as directors of the company we hereby confirm:

(a) that for the year stated above the company was entitled to the exemption conferred by section 477 of the Companies Act 2006 ;

(b) that no notice has been deposited at the registered office of the company pursuant to section 476 of the Companies Act 2006 requesting that an audit be conducted for the year ended 31 December 2025.

(c) that we acknowledge our responsibilities for:

(i) ensuring that the company keeps proper accounting records which comply with section 386 of the Companies Act 2006, and

(ii) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit or loss for the year then ended in accordance with the requirements of sections 394 and 395, and which otherwise comply with the provisions of the Companies Act relating to financial statements, so far as applicable to the company.

The financial statements were approved by the board on 6[th] August 2026 and signed on its behalf by

.................................

Mr M Coleman

Director

Page 9

Bowel Cancer West (A company limited by guarantee)

Notes to the financial statements for the period ended 31 December 2025

1. Accounting policies

The principal accounting policies are summarised below. The accounting policies have been applied consistently throughout the year and the preceding year.

1.1. Basis of accounting

The financial statements have been prepared in accordance with Accounting and Reporting by Charities Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. Bowel Cancer West meets the definition of a public benefit entity under FRS 102. The trustees consider that there are no material uncertainties about the Charity's ability to continue as a going concern. The Charity's functional and presentational currency is the pound sterling.

1.2. Incoming resources

All incoming resources are included in the statement of financial activities when the charity is entitled to the income, and the amount can be quantified with reasonable accuracy. The following specific policies are applied to categories of income:

1.3. Resources expended

Expenditure is recognised on an accrual basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered and is reported as part of the expenditure to which it relates.

Costs of generating funds comprise the costs associated with attracting voluntary income and the costs of trading for fundraising purposes including the charity's shop. Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them. Governance costs include those costs associated with meeting the constitutional and statutory requirements of the charity and include the costs linked to the strategic management of the charity.

Page 10

Bowel Cancer West (A company limited by guarantee)

Notes to the financial statements for the period ended 31 December 2025

1.4. Tangible fixed assets and depreciation

Tangible fixed assets are stated at cost less accumulated depreciation. Depreciation is provided at rates calculated to write off the cost less residual value of each asset over its expected useful life, as follows:

Fixtures, fittings and equipment - 25% of net book value per annum Leasehold – 20% straight line

1.5. Investment Policy

The income is held in a business current account and business reserve account with Natwest Bank. All transactions and business costs are free of charge and there is no interest paid on the account balance.

1.6. Defined contribution pension schemes

The pension costs charged in the financial statements represent the contribution payable by the company during the year.

2. Voluntary income

Online Just Giving
Donations
Fundraising
Collection tins
Events
Goods sold
Charity Shop Income
Other Trading Income
2025
Total
£
7,450
5,041
7,755
279
16,339
1,027
4,172
3,049
_
45,112
2024
Total
£
8,845
11,639
19,591
316
17,540
129
21,636
2,012
_
81,708

Page 11

Bowel Cancer West (A company limited by guarantee)

Notes to the financial statements for the period ended 31 December 2025

3. Investment income

Bank interest receivable
nts
Grants received
2024
Total
£
30
_
30
_
2025
Total
£
-
_
-
2024
Total
£
22
_
22
_
2024
Total
£
-
_
-

4. Grants

Page 12

Bowel Cancer West

(A company limited by guarantee)

Notes to the financial statements for the period ended 31 December 2025

5. Governance costs

Accountancy and payroll fees
Depreciation
6. Net outgoing resources for the year
Net outgoing resources is stated after charging:
Depreciation and other amounts written off tangible fixed assets
2025
Total
£
1,874
2,441
_
4,315
_
2025
£
2,441
2024
Total
£
1,591
2,494
_
4,085
_
2024
£
2,494

Page 13

Bowel Cancer West

(A company limited by guarantee)

Notes to the financial statements for the period ended 31 December 2025

7. Employees

Employment costs
Wages and salaries
Pension costs
2025
£
23,955
316
_
24,271
2024
£
33,299
436
_
33,735

No employee received emoluments of more than £60,000 (2024: None)

8. Number of employees

The average monthly numbers of employees (including the trustees) during the year, calculated on the basis of full-time equivalents, was as follows:

2025
Number
10
2024
Number
12

9. Pension costs

The company operates a defined contribution pension scheme in respect of the employee. The scheme and its assets are held by independent managers. The pension charge represents contributions due from the company and amounted to £316 (2024 - £436).

Pension charge 2025
£
316
2024
£
436

Page 14

Bowel Cancer West (A company limited by guarantee)

Notes to the financial statements for the period ended 31 December 2025

10. Taxation

The charity's activities fall within the exemptions afforded by the provisions of the Income and Corporation Taxes Act 1988. Accordingly, there is no taxation charge in these accounts.

Fixtures,
11.
Tangible fixed assets
Leasehold
fittings and
equipment
£
Cost
At 1 January 2025 and 11,399 5,828
At 31 December 2025
11,399
5,828
_
_
Depreciation
At 1 January 2025
6,839
5,183
Charge for the year
2,280
161
_
_
At 31 December 2025
9,119
5,344
_
_
Net book values
At 31 December 2025
2,280
484
_
_
At 31 December 2024
4,560
645

Fixtures,
11.
Tangible fixed assets
Leasehold
fittings and
equipment
£
Cost
At 1 January 2025 and 11,399 5,828
At 31 December 2025
11,399
5,828
_
_
Depreciation
At 1 January 2025
6,839
5,183
Charge for the year
2,280
161
_
_
At 31 December 2025
9,119
5,344
_
_
Net book values
At 31 December 2025
2,280
484
_
_
At 31 December 2024
4,560
645

Fixtures,
11.
Tangible fixed assets
Leasehold
fittings and
equipment
£
Cost
At 1 January 2025 and 11,399 5,828
At 31 December 2025
11,399
5,828
_
_
Depreciation
At 1 January 2025
6,839
5,183
Charge for the year
2,280
161
_
_
At 31 December 2025
9,119
5,344
_
_
Net book values
At 31 December 2025
2,280
484
_
_
At 31 December 2024
4,560
645

Total
£
17,277
17,227
_
12,022
2,441
_
14,463
_
2,764
_
5,205
_
6,839
2,280
_
9,119
_
2,280
_
4,560
_
5,183
161
_
5,344
_
484
_
645

Page 15

Bowel Cancer West (A company limited by guarantee)

Notes to the financial statements for the period ended 31 December 2025

12. Debtors

Trade debtors
Other debtors
Prepayments
Other debtors – rent deposit
13.
Creditors: amounts falling due
within one-year
Trade creditors
Other taxes and social security
Pension creditors
Accruals and deferred income
2025
£
-
147
270
-
_
417
_
2025
£
-
136
-
1,207
_
1,343
2024
£
-
335
1,965
1,000
_
3,300
_
2024
£
-
93
98
2,081
_
2,272

Page 16

Bowel Cancer West

(A company limited by guarantee)

Notes to the financial statements for the period ended 31 December 2025

14. Analysis of net assets between funds

Fund balances at 31 December 2025 as represented by:
Tangible fixed assets
Current assets
Current liabilities
15.
Unrestricted funds
1
General Funds
Unrestricted
Total
funds
funds
£
£
2,764
2,764
26,190
26,190
(1,343)
(1,343)
_
_
27,611
27,611
_
_
At
At
January
Incoming
Outgoing 31 December
2025
resources
resources
2025
£
£
£
£
35,469
45,142
53,000
27,611



Total
funds
£
2,764
26,190
(1,343)
_
27,611

16. Contingent liabilities

There were no contingent liabilities at the balance sheet date.

Page 17

Bowel Cancer West

(A company limited by guarantee)

The following pages do not form part of the statutory accounts.

Bowel Cancer West (A company limited by guarantee)

Incoming resources
Voluntary income
Online Just Giving
Donations
Fundraising
Collection tins
Events
Goods Sold
Charity Shop Income
Other trading income
Other Incoming resources
Grants received
Investment income
Bank interest receivable
Total incoming resources
2025
£
7,450
5,041
7,755
279
16,339
1,027
4,172
3,049
_
45,112
_
2025
£
-
_
2025
£
30
_
30
_
45,142
2024
£
8,845
11,639
19,591
316
17,540
129
21,636
2,012
_
81,708
_
2024
£
-
_
-
2024
£
22
_
22
_
81,730

Bowel Cancer West (A company limited by guarantee)

Charitable activities

Activity 1

Activities undertaken directly
Wages and salaries
Pension costs
Online Just Giving fees
Promotional and marketing
Website
Event costs
Rent & Rates
Light & Heat
Charitable Shop Costs
BCW Administration
Public Liability Insurance
Pension Charges
Bank & Paypal Charges
Training and workshops
Total charitable activity expenditure
Governance costs
Activities undertaken directly
Accountancy and payroll fees
Depreciation
Total governance costs
Net incoming/(outcoming) resources for the year
23,955
316
216
5,464
2,451
6,447
6,991
1,414
38
253
535
120
24
461
_
1,874
2,441
_
48,685
__
48,685
_
4,315
_
4,315
____
(7,858)
33,299
436
216
11,404
2,008
7,256
12,993
1,291
489
4,508
985
180
34
245
_
1,591
2,494
_
75,344
_
75,344
_
4,085
_
4,085
_
2,301
_
_